Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity - Non-Vested Restricted Stock Units Activity (Details)

v3.22.2.2
Shareholders' Equity - Non-Vested Restricted Stock Units Activity (Details)
9 Months Ended
Oct. 29, 2022
$ / shares
shares
Market Based Restricted Stock Units  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 57,800
Granted, shares | shares 0
Vested, shares | shares 0
Forfeited, shares | shares 0
Expired, shares | shares (12,500)
Non-vested restricted stock shares outstanding at end of period | shares 45,300
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 3.47
Granted, weighted average grant date fair value per share | $ / shares 0
Vested, weighted average grant date fair value per share | $ / shares 0
Forfeited, weighted average grant date fair value per share | $ / shares 0
Expired, weighted average grant date fair value per share | $ / shares 5.07
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 3.02
Restricted Stock Units Time Based  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 1,031,300
Granted, shares | shares 985,600
Vested, shares | shares (453,000)
Forfeited, shares | shares (78,600)
Non-vested restricted stock shares outstanding at end of period | shares 1,485,300
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 7.46
Granted, weighted average grant date fair value per share | $ / shares 3.71
Vested, weighted average grant date fair value per share | $ / shares 6.67
Forfeited, weighted average grant date fair value per share | $ / shares 5.02
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 5.34
Performance Based Units  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 222,900
Granted, shares | shares 36,400
Non-vested restricted stock shares outstanding at end of period | shares 259,300
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 4.13
Granted, weighted average grant date fair value per share | $ / shares 1.69
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 3.79
Restricted Stock Units (RSUs)  
Summary of changes in Company's non-vested restricted stock during period [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period | shares 1,312,000
Granted, shares | shares 1,022,000
Vested, shares | shares (453,000)
Forfeited, shares | shares (78,600)
Expired, shares | shares (12,500)
Non-vested restricted stock shares outstanding at end of period | shares 1,789,900
Summary of changes in Company's non-vested restricted stock during period, weighted average grant date fair value [Roll Forward]  
Non-vested restricted stock shares outstanding at beginning of period, weighted average grant date fair value per share | $ / shares $ 6.72
Granted, weighted average grant date fair value per share | $ / shares 3.64
Vested, weighted average grant date fair value per share | $ / shares 6.67
Forfeited, weighted average grant date fair value per share | $ / shares 5.02
Expired, weighted average grant date fair value per share | $ / shares 5.07
Non-vested restricted stock shares outstanding at end of period, weighted average grant date fair value per share | $ / shares $ 5.06